MSD Secures Reimbursement Approval for Von Hippel-Lindau Treatment in Italy
MSD’s belzutifan treatment for Von Hippel-Lindau syndrome receives reimbursement approval in Italy
MSD’s belzutifan treatment for Von Hippel-Lindau syndrome receives reimbursement approval in Italy
Salutequità, Ail, and Apfiaco are urging the Italian Ministry of Health to include chronic conditions such as psoriasis and hematological neoplasms in the National Chronicity Plan to improve patient care and reduce hospital congestion
Thena Capital, an all-female GP firm, has closed £45m for its debut fund to support startups in digital healthcare and medical devices in the UK, with plans to help them enter the US market.
GymBeam, a European fitness e-commerce platform, expands to Vienna and Milan, securing 30 million euros in funding from the European Bank for Reconstruction and Development.
UK-based Joyvié Health raises €897k to develop continence underwear designed to reduce stool-to-skin contact and caregiver burden
Johnson & Johnson presented final results of phase 3 study Proteus, showing that treatment with apalutamide, an androgen receptor inhibitor, associated with androgen deprivation therapy (ADT), administered for six months before and after surgical intervention for prostate cancer, leads to significant improvement in main short-term and long-term clinical outcomes
Katerina Spranger, a Ukrainian-born entrepreneur, won the European Prize for Women Innovators with her startup Oxford Heartbeat, which uses AI to improve the safety and accuracy of cerebral aneurysm treatments.
Semble raises £30M Series C to expand its healthcare management platform
Caresyntax, a Berlin-based healthtech startup founded by Björn von Siemens, has filed for insolvency. The company developed digital assistance systems for operating rooms to reduce human error during surgeries.
Cegedim Santé acquired Médoucine, a French healthtech startup often referred to as ‘the Doctolib of alternative medicine’